Blue Cross Blue Shield and PacificSource Health Plans are opposing a bill that would regulate their payment disputes with air ambulance companies, arguing the legislation would require them to raise rates, reports Bozeman Daily Chronicle.
The Latest
HHS launched a "day of action" campaign Jan. 12 for artists to share how the ACA affected them amid Congress' efforts to quickly repeal and replace the health law.
CVS Pharmacy said it was not its "desire or decision" to leave a Blue Cross and Blue Shield of Alabama pharmacy network providing coverage for 390,000 policyholders, reports AL.com.
Indianapolis-based Anthem inked a multiyear extension of its partnership with health IT company Inovalon in Bowie, Md.
The following health insurers made headlines this week. They are listed below, beginning with the most recent.
Chicago-based Blue Cross Blue Shield Association issued a positive assessment of Seattle-based NanoString's Prosigna Breast Cancer assay.
Bloomfield, Conn.-based Cigna dropped coverage for Mylan's EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer's prescription drug list changes, which were effective Jan. 7.
An Austin, Texas-based health plan charging members a small fee for access to primary and urgent care physicians extended its direct care network in Connecticut.
The number of North Carolina residents who enrolled in health plans through the federal exchange this year fell from the same period last year, The News & Observer reports.
Four of the nation's largest health insurers are entrenched in antitrust trials over concerns their proposed consolidations will impede competition. And with such insurer mergers, market concentration plays a key role when insurers and providers bargain over commercial healthcare prices,…